0
Views
0
CrossRef citations to date
0
Altmetric
Respiratory Medicine

Cost-effectiveness analysis of budesonide/formoterol SMART therapy versus salmeterol/fluticasone plus as-needed SABA among patients ≥12 years with moderate asthma from the Chinese societal perspective

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, &
Received 13 Jun 2024, Accepted 24 Jul 2024, Accepted author version posted online: 27 Jul 2024
Accepted author version